This inventor holds 1 USPTO granted patent. Top assignee: Sonofi. Active years: 1984.
Company Filing History:
Years Active: 1984
Title: Claude Moulineau: Innovator in Pharmaceutical Compositions
Introduction
Claude Moulineau is a notable inventor based in Montpellier, France. He has made significant contributions to the field of pharmaceuticals, particularly in developing compositions that have a peripheral antagonistic action with respect to opiates. His work is essential in advancing medical treatments and improving patient care.
Latest Patents
Moulineau holds a patent for a pharmaceutical composition that includes a haloallylate of levallorphan as the active ingredient. This composition is designed to provide a peripheral antagonistic action against opiates, which can be crucial in managing pain and reducing the risk of addiction. The patent highlights the innovative approach to utilizing specific chemical compounds to enhance therapeutic outcomes.
Career Highlights
Throughout his career, Claude Moulineau has demonstrated a commitment to research and development in the pharmaceutical industry. His work at Sanofi, a leading global healthcare company, has allowed him to collaborate with other experts in the field and contribute to groundbreaking advancements in medicine. His dedication to innovation is evident in his patent and ongoing research efforts.
Collaborations
Moulineau has worked alongside talented colleagues, including Antonina Giudice and Luciano Manara. These collaborations have fostered a creative environment that encourages the exchange of ideas and expertise, ultimately leading to more effective pharmaceutical solutions.
Conclusion
Claude Moulineau's contributions to pharmaceutical compositions reflect his innovative spirit and dedication to improving healthcare. His patent and collaborations with esteemed colleagues underscore the importance of teamwork in advancing medical science. His work continues to impact the field positively.